Protein biotherapeutics have gone from a seldom used subset of treatments to a multi-billion dollar global industry. With the ever-expanding protein therapeutic market,
SMi`s 6th annual Global Protein Summit 2010 is well timed to investigate the latest developments in protein therapeutics, cell culture expression and immunogenicity.
The conference will explore the next generation of protein therapeutics, how they are being developed and reassess the technology, discovery and delivery trends. Also covered will be expression optimisation, case studies looking at successful drugs along with immunogenic considerations and safety assessment.
Reassess the latest therapeutics, developments, technologies, and methods that work in an interactive, networking friendly environment with major players from the biotech industry.
This meeting will feature talks from experts who will address: - Optimisation of pre-formulation approaches, expression and glycosylation
- Next generation nanobodies
- Generating therapeutic antibodies to multi-transmembrane receptors
- Case studies in successful innovative biotherapeutics
- In silico methods to reduce development risks
- Recognising and combating immunogenicity
- Regulatory perspectives
